COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020

Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine...

Descripción completa

Detalles Bibliográficos
Autores principales: Bénézit, François, Le Bot, Audrey, Jouneau, Stéphane, Lemaître, Florian, Pronier, Charlotte, Lentz, Pierre-Axel, Patrat-Delon, Solène, Revest, Matthieu, Thibault, Vincent, Tattevin, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510728/
https://www.ncbi.nlm.nih.gov/pubmed/32609083
http://dx.doi.org/10.3201/eid2610.201816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510728/
https://www.ncbi.nlm.nih.gov/pubmed/32609083
http://dx.doi.org/10.3201/eid2610.201816

Ejemplares similares